Global Gastroparesis Market 2017 Analysis and Growth Forecast To 2023

Market Research add new report of “Gastroparesis Market Research Report – Global Forecast To 2023” it contains Company information, geographical data and Table of Content

Global Gastroparesis Treatment Market Has Been Segmented On The Basis Of Gastroparesis Type Which Comprises Idiopathic, Diabetic, Post-Surgical And Others. On The Basis Of Drug Class The Market Comprises Of Prokinetic Drugs, Antiemetics, Antidepressants And Others. On The Basis Of Other Treatment; Market Is Segmented Into Jejunostomy, Gastric Electric Stimulation (GES) And Parenteral Nutrition.

Gastroparesis Is A Condition Of Delayed Gastric Emptying Because Of Partial Paralysis Of The Stomach, Resulting In Food Remaining In The Stomach For An Abnormally Long Time. The Gastric Muscles Contracts To Move Food Down Into The Small Intestine Which Is Controlled By The Vagus Nerve. Damage To The Vagus Nerve Or The Muscles Of The Stomach And Intestines Causes Food To Move Slowly Resulting In Gastroparesis. Gastroparesis Predominantly Affects Young Adult Females. Although Gastroparesis Is Frequently Associated With Diabetes, Idiopathic Gastroparesis Accounts For The Greatest Number Of Cases.The Other Market Driving Factors Of Gastroparesis Are Surgery On The Stomach Or Vagus Nerve, Anorexia Nervosa, Use Of Narcotics That Slow Gastric Contractions, Gastro Esophageal Reflux Disease, Disorders, Such As Amyloidosis And Scleroderma, Parkinson’s Disease, Metabolic Disorders Such As Hypothyroidism Etc. The Global Market For Gastroparesis Treatment Is Expected To Reach Around USD 5,323.62 Million By The End Of The Forecast Period And Is Expected To Grow At A CAGR Of ~ 3.8 %.

Request a Sample Report @

Key Players for Global Gastroparesis Treatment Market:

Kimberly-Clark Corporation

Abbott Laboratories

Salix Pharmaceuticals, Inc.

Boston Scientific Corporation

  1. R. Bard, Inc.

Janssen Global Services


Cardinal Health, Inc.

Alfa Wassermann SPA

Evoke Pharma

Rhythm Pharmaceuticals, Inc.

Regional Analysis Of Global Gastroparesis Treatment Market:

Globally America Is The Largest Market For Gastroparesis Treatment. Europe Is The Second-Largest Market For Gastroparesis Treatment. Reasons For Dominance Of The Developed Regions Is The Faster Market Uptake, Higher Per Capita Income And Excellent Reimbursement Scenario In These Regions. Asia Pacific Region Is Expected To Be Witness Fastest Growth And Most Of It Will Be Led By Japan, China And India.
The Report For Global Gastroparesis Treatment Market Of Market Research Future Comprises Extensive Primary Research Along With The Detail Analysis Of Qualitative As Well As Quantitative Aspects By Various Industry Experts, Key Opinion Leaders To Gain The Deeper Insight Of The Market And Industry Performance. The Report Gives The Clear Picture Of Current Market Scenario Which Includes Historical And Projected Market Size In Terms Of Value And Volume, Technological Advancement, Macro Economical And Governing Factors In The Market. The Report Provides Detail Information And Strategies Of The Top Key Players In The Industry. The Report Also Gives A Broad Study Of The Different Markets Segments And Regions.

Browse Full Report Details@

Table Of Content

1    Introduction

1.1    Definition

1.2    Scope Of Study

1.3    Research Objective

1.4    Assumptions & Limitations

1.5    Market Structure:

2    Research Methodology

2.1    Research Process

2.2    Primary Research

2.3    Secondary Research

3    Market Dynamics

3.1    Drivers

3.2    Restraints

3.3    Opportunities

3.4    Challenges

3.5    Macroeconomic Indicators

4    Market Factor Analysis

4.1    Porter’s Five Forces Model

4.1.1    Bargaining Power Of Suppliers

4.1.2    Bargaining Power Of Customer

4.1.3    Intensity Of Competitor’s

4.1.4    Threat Of New Entrants

10    Company Profile

10.1    Medtronic

10.1.1    Company Overview

10.1.2    Product/Business Segment Overview

10.1.3    Financials

10.1.4    Key Developments

10.1.5    SWOT Analysis

10.2    Kimberly-Clark Corporation

10.2.1    Overview

10.2.2    Product/Business Segment Overview

10.2.3    Financials

10.2.4    Key Developments

10.2.5    SWOT Analysis

10.3    Abbott Laboratories

10.3.1    Overview

10.3.2    Product/Business Segment Overview

10.3.3    Financials

10.3.4    Key Developments

10.3.5    SWOT Analysis

10.4    Salix Pharmaceuticals, Inc.

10.4.1    Overview

10.4.2    Product/Business Segment Overview

10.4.3    Financials

10.4.4    Key Developments

10.4.5    SWOT Analysis

10.5    Boston Scientific Corporation

10.5.1    Overview

10.5.2    Product/Business Segment Overview

10.5.3    Financials

10.5.4    Key Developments

10.5.5    SWOT Analysis

10.6    C. R. Bard, Inc.

10.6.1    Overview

10.6.2    Product/Business Segment Overview

10.6.3    Financials

10.6.4    Key Developments

10.6.5    SWOT Analysis

10.7    Rhythm Pharmaceuticals, Inc.

10.7.1    Overview

10.7.2    Product/Business Segment Overview

10.7.3    Financials

10.7.4    Key Developments

10.7.5    SWOT Analysis

10.8    Cardinal Health, Inc.

10.8.1    Overview

10.8.2    Product/Business Segment Overview

10.8.3    Financials

10.8.4    Key Developments

10.8.5    SWOT Analysis

10.9    Alfa Wassermann SPA

10.9.1    Overview

10.9.2    Product/Business Segment Overview

10.9.3    Financials

10.9.4    Key Developments

10.9.5    SWOT Analysis

10.10    Evoke Pharma

10.10.1    Overview

10.10.2    Product/Business Segment Overview

10.10.3    Financials

10.10.4    Key Developments

10.10.5    SWOT Analysis


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.



Akash Anand,

Market Research Future

+1 646 845 9312





%d bloggers like this: